Prof. Grandi is an Italian scientist who took leading positions in industrial research, including Head of the Biotechnology Centers of ENIRICERCHE and Director of the Biochemistry and Molecular Biology Department of the Vaccines Division of Chiron.
When Chiron was acquired by Novartis, Prof. Grandi was appointed Senior Project Leader and Member of the Board of Directors of Novartis Vaccines and Diagnostics, Italy.
At Novartis, he led/co-led numerous successful vaccine projects including Meningococcus B vaccine, Group A and Group B Streptococcus vaccine and Staphylococcus aureus vaccine. In 2015 he became Professor of Microbiology and Clinical Microbiology at Trento University, Italy.
In addition, Grandi is a permanent member of the European Molecular Biology Organization as well as a number of scientific advisory boards, the co-founder of two Biotech Companies working in the field of cancer immunotherapy, inventor/co-inventor of 448 granted international patents, author/co-author of 185 publications on international peer-reviewed papers and 20 book chapters, and is editor/co-editor of three books.